Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC11576392/ The BNT162b2 mRNA vaccine demonstrates reduced age-associated TH1 support in vitro and in vivo - PMC mRNA vaccines demonstrate impaired immunogenicity and durability in vulnerable older populations. We hypothesized that human in vitro modeling and proteomics... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1136029/full Frontiers | mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific... Introduction: COVID-19 vaccines based on mRNA have represented a revolution in the biomedical research field. The initial two-dose vaccination schedule gener... https://pmc.ncbi.nlm.nih.gov/articles/PMC8946961/ Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in... Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and BioNTech, showed reversible hepatic effects in animals that received the... covid 19 mrna vaccine https://www.mdpi.com/2076-393X/9/11/1357 Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2... Background: Studies reporting the long-term humoral response after receiving the BNT162b2 COVID-19 vaccine are important to drive future vaccination... https://www.mdpi.com/2076-393X/12/2/174 Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell... Background: Allogeneic hematopoietic stem cell transplantation (ASCT) induces acquired immunodeficiency, potentially altering vaccine response. Herein, we... mrna vaccine https://www.acc.org/latest-in-cardiology/journal-scans/2020/12/14/18/58/safety-and-efficacy-of-the-bnt162b2 Safety and Efficacy of BNT162b2 mRNA COVID-19 Vaccine - American College of Cardiology Salim Hayek, MD, FACC covid 19 vaccine https://pmc.ncbi.nlm.nih.gov/articles/PMC8656165/ Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster... Since nucleoside-modified mRNA vaccines strongly activate T follicular helper cells, it is important to explore the possible impact of approved SARS-CoV-2 mRNA... t cell lymphoma https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-reach-agreement-supply-eu-200-million Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2... Agreement provides a supply of 200 million doses and an option to request additional 100 million doses, with deliveries anticipated to start by the end of... https://pmc.ncbi.nlm.nih.gov/articles/PMC7745181/ Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine - PMC Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of... covid 19 vaccineof thesafetyefficacy https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.859019/full Frontiers | Humoral and Cellular Responses to BNT162b2 as a Booster Following Two Doses of ChAdOx1... Data on humoral and cellular responses to BNT162b2 as a booster dose, following two doses of ChAdOx1 nCov-19 vaccine, have seldom been reported. The aim of t... https://www.preprints.org/manuscript/202311.0182 BNT162b2 Booster Dose Elicits a Robust Antibody Response in Subjects with Abdominal Obesity and... Little is known about the long-term durability of the induced immune response in subjects af-fected by obesity, particularly in those with an abdominal... https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1221587/full Frontiers | Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2... Background: Few data are available about the durability of the response, the induction of neutralizing antibodies, and the cellular response upon the third d... https://www.mdpi.com/1467-3045/44/3/73 Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in... Preclinical studies of COVID-19 mRNA vaccine BNT162b2, developed by Pfizer and BioNTech, showed reversible hepatic effects in animals that received the... covid 19 mrna vaccine https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2021/05/07/15/37/Impact-and-Effectiveness-of-mRNA Effectiveness of mRNA BNT162b2 Vaccine Against COVID-19 in Israel - American College of Cardiology Salim Hayek, MD, FACC https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1534787/full Frontiers | Gut microbiota is associated with persistence of longer-term BNT162b2 vaccine... IntroductionBNT162b2 immunogenicity wanes with time and we investigated association between gut microbiota and longer-term immunogenicity.MethodsThis cohort ... gut microbiotaassociated with https://www.businesswire.com/news/home/20201210005703/en/Pfizer-and-BioNTech-Announce-Publication-of-Results-from-Landmark-Phase-3-Trial-of-BNT162b2-COVID-19-Vaccine-Candidate-in-The-New-England-Journal-of-Medicine Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2... Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the New England Journal of Medicine has published safety and final efficacy resul... publication of results https://www.cdc.gov/mmwr/volumes/71/wr/mm7102e1.htm Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory... Jan 13, 2022 - This report describes how effective Pfizer-BioNTech COVID-19 vaccination was against multisystem inflammatory syndrome in children (MIS-C). pfizer biontecheffectivenessbnt162b2mrnavaccination https://www.news-medical.net/news/20220329/Study-explores-the-waning-efficacy-of-SARS-CoV-2-ChAdOx1-and-BNT162b2-vaccines.aspx Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines May 18, 2023 - A new study evaluated the waning efficacy of the COVID-19 ChAdOx1 and BNT162b2 vaccines over six months following the second dose. sars cov 2 https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-publication-results-landmark Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2... Data from 43,448 participants, half of whom received BNT162b2 and half of whom received placebo, showed that the vaccine candidate was well tolerated and... publication of results https://www.mdpi.com/2076-393X/12/5/516 Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and... SARS-CoV-2 vaccination-induced protection against infection is likely to be affected by functional antibody features. To understand the kinetics of antibody... https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2021/12/31/20/41/BNT162b2-Vaccine-Booster BNT162b2 Vaccine Booster and Mortality Due to COVID-19 - American College of Cardiology Salim Hayek, MD, FACC mortality due to covid 19 https://www.news-medical.net/news/20211029/Study-finds-immunity-against-SARS-CoV-2-delta-variant-waned-after-BNT162b2-vaccine-second-dose.aspx Study finds immunity against SARS-CoV-2 delta variant waned after BNT162b2 vaccine second dose Oct 31, 2021 - Researchers from Israel have investigated the possibility that vaccine-induced immunity reduces over time and potential causes and risk factors. sars cov 2 delta variant https://www.news-medical.net/news/20210730/BNT162b2-vaccine-shows-high-efficacy-at-six-months.aspx BNT162b2 vaccine shows high efficacy at six months Apr 12, 2023 - The Pfizer/BioNTech vaccine appears to be highly effective in protecting against the SARS-CoV-2 infection, including its relatively resistant beta variant... high efficacyat sixbnt162b2vaccineshows https://www.mdpi.com/2076-393X/11/10/1578 Twenty-Month Monitoring of Humoral Immune Response to BNT162b2 Vaccine: Antibody Kinetics,... Background: Vaccination is one of the most effective life-saving medical interventions, and the introduction of SARS-CoV-2 vaccines was intended to prevent the... humoral immune response https://www.rivm.nl/publicaties/high-sars-cov-2-antibody-levels-after-three-consecutive-bnt162b2-booster-vaccine-doses High SARS-CoV-2 antibody levels after three consecutive BNT162b2 booster vaccine doses in nursing...